Emma Niméus

2.8k total citations
40 papers, 816 citations indexed

About

Emma Niméus is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Emma Niméus has authored 40 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cancer Research, 20 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Emma Niméus's work include Breast Cancer Treatment Studies (13 papers), Cancer Cells and Metastasis (11 papers) and Cancer Genomics and Diagnostics (10 papers). Emma Niméus is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Cancer Cells and Metastasis (11 papers) and Cancer Genomics and Diagnostics (10 papers). Emma Niméus collaborates with scholars based in Sweden, United States and Switzerland. Emma Niméus's co-authors include Martin Sjöström, Mårten Fernö, Ruedi Aebersold, Per Malmström, Ruth Hüttenhain, Per Karlsson, Oliver Rinner, Atul Sethi, Christine Carapito and Terry Farrah and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Emma Niméus

36 papers receiving 799 citations

Peers

Countries citing papers authored by Emma Niméus

Since Specialization

Citations

This map shows the geographic impact of Emma Niméus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Niméus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Niméus more than expected).

Fields of papers citing papers by Emma Niméus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Niméus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Niméus. The network helps show where Emma Niméus may publish in the future.

Co-authorship network of co-authors of Emma Niméus

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Niméus. A scholar is included among the top collaborators of Emma Niméus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Niméus. Emma Niméus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT: a randomized clinical trial with long-term follow-up 2025 ·BMC Cancer ·(unknown), Tommaso De Marchi, Niklas Schultz, Lena Tran, Per Karlsson, Erik Holmberg, Gyula Pekár, Fredrika Killander, Emma Niméus	0
2	The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably? 2024 ·EClinicalMedicine ·(unknown), Nikos Tsiknakis, Johan Staaf, Ana Bosch, Anna Ehinger, Emma Niméus, Roberto Salgado, Yalai Bai, David L. Rimm, Johan Hartman, Balázs Ács	6
3	Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling 2024 ·Scientific Reports ·Tommaso De Marchi, Chun‐Fui Lai, (unknown), (unknown), Alison Harrod, (unknown), Lakjaya Buluwela, Sven Kjellström, Christian Brueffer, Lao H. Saal, Johan Malmström, Simak Ali, Emma Niméus	6
4	Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms 2023 ·Breast Cancer Research ·(unknown), Tommaso De Marchi, Anna Ehinger, Johan Hartman, Ana Bosch, Johan Staaf, Fredrika Killander, Emma Niméus	14
5	Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long‐term follow‐up of the SweBCG91RT randomized trial 2023 ·Molecular Oncology ·(unknown), Tommaso De Marchi, Gyula Pekár, Lena Tran, Pär‐Ola Bendahl, (unknown), Erik Holmberg, Per Karlsson, Marianne Farnebo, Fredrika Killander, Emma Niméus	3
6	A somatic mutation in moesin drives progression into acute myeloid leukemia 2022 ·Science Advances ·(unknown), Amol Ugale, Tommaso De Marchi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jenny Hansson, Isabel Hidalgo, Talía Velasco-Hernández, Jörg Cammenga, Jeffrey A. Magee, Emma Niméus, David Bryder	2
7	Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up 2022 ·British Journal of Cancer ·(unknown), Martin Sjöström, Erik Holmberg, Per Karlsson, Fredrika Killander, L.M. Fredrik Leeb-Lundberg, Per Malmström, Emma Niméus, Mårten Fernö, Annika Jögi	34
8	Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics 2022 ·Molecular Metabolism ·Ugo Chianese, (unknown), (unknown), (unknown), (unknown), (unknown), Tommaso De Marchi, Emma Niméus, Vincenzo Carafa, (unknown), Nunzio Del Gaudio, Nunzia Iaccarino, Antonio Randazzo, Dante Rotili, Antonello Mai, Salvatore Cappabianca, Alireza Mashaghi, Fortunato Ciardiello, Lucia Altucci, Rosaria Benedetti	9
9	An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer 2021 ·Clinical Cancer Research ·Yalai Bai, Kimberly Cole, Sandra Martínez-Morilla, Fahad Shabbir Ahmed, Jon Zugazagoitia, Johan Staaf, Ana Bosch, Anna Ehinger, Emma Niméus, Johan Hartman, Balázs Ács, David L. Rimm	38
10	Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast Cancer 2021 ·Cancers ·Rosaria Benedetti, (unknown), (unknown), Ugo Chianese, Tommaso De Marchi, Francesco Iovino, Dante Rotili, Antonello Mai, Emma Niméus, (unknown), Lucia Altucci	14
11	Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly 2021 ·Breast Cancer Research ·Mattias Aine, (unknown), Johan Hartman, Jari Häkkinen, Shamik Mitra, Ana Bosch Campos, Emma Niméus, Anna Ehinger, Johan Vallon‐Christersson, Åke Borg, Johan Staaf	2
12	Molecular analyses of triple-negative breast cancer in the young and elderly 2021 ·Breast Cancer Research ·Mattias Aine, (unknown), Johan Hartman, Jari Häkkinen, Shamik Mitra, Ana Bosch Campos, Emma Niméus, Anna Ehinger, Johan Vallon‐Christersson, Åke Borg, Johan Staaf	30
13	Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial 2020 ·Clinical Cancer Research ·(unknown), Henri Puttonen, Martin Sjöström, Erik Holmberg, S. Laura Chang, Felix Y. Feng, Corey Speers, Lori J. Pierce, Dan Lundstedt, Fredrika Killander, Emma Niméus, Anikó Kovács, Per Karlsson	17
14	A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer 2019 ·Molecular & Cellular Proteomics ·Ruth Hüttenhain, Meena Choi, (unknown), Kathrin Oehl, (unknown), (unknown), Susanne Malander, Håkan Olsson, Silvia Šurinová, Timothy Clough, Viola Heinzelmann‐Schwarz, Peter J. Wild, Daniela M. Dinulescu, Emma Niméus, Olga Vitek, Ruedi Aebersold	38
15	Similarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MS 2018 ·Cell Reports ·Tatjana Sajic, Yansheng Liu, Eirini Arvaniti, Silvia Šurinová, Evan G. Williams, Ralph Schiess, Ruth Hüttenhain, Atul Sethi, Sheng Pan, Teresa A. Brentnall, Ru Chen, Peter Blattmann, (unknown), Emma Niméus, Susanne Malander, Aurelius Omlin, Silke Gillessen, Manfred Claassen, Ruedi Aebersold	33
16	Androgen Receptor in Stage I-II Primary Breast Cancer –Prognostic Value and Distribution in Subgroups 2017 ·Anticancer Research ·Emma Niméus, (unknown), Björn Nodin, Linda Hartman, Marie Klintman	6
17	Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases 2015 ·Clinical Proteomics ·(unknown), Martin Sjöström, Morten Krogh, (unknown), Dorthe Grabau, Karin Hansson, Lisa Rydén, Sofia Waldemarson, Peter James, Emma Niméus	18
18	Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy 2008 ·Breast Cancer Research ·Emma Niméus, Morten Krogh, Per Malmström, Carina Strand, Irma Fredriksson, Per Karlsson, Bo Nordenskjöld, Olle Stål, G Ostberg, Carsten Peterson, Mårten Fernö	48
19	Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy 2006 ·European Journal of Cancer ·Emma Niméus, (unknown), Patrik Edén, Anders Johnsson, Mattias Ohlsson, Carina Strand, G Ostberg, Mårten Fernö, Carsten Peterson	20
20	Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck 2004 ·Oral Oncology ·Emma Niméus	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact